Management of Hailey-Hailey Disease With Ruxolitinib 1.5% Cream

Ruxolitinib may be an effective treatment option for HHD management, but further investigation is necessary.

Authors

Publication Details

Journal
Journal of Drugs in Dermatology
Published
2025-10-01
DOI
https://doi.org/10.36849/jdd.9351
Primary Topic
Genetic and rare skin diseases.
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Management of Hailey-Hailey Disease With Ruxolitinib 1.5% Cream

Héctor Quijano Méndez, Jacob Beer, Mounika Vattigunta
Journal of Drugs in Dermatology
Genetic and rare skin diseases.
article

Management of Hailey-Hailey Disease With Ruxolitinib 1.5% Cream

Héctor Quijano Méndez, Jacob Beer, Mounika Vattigunta
article en

Abstract

Ruxolitinib may be an effective treatment option for HHD management, but further investigation is necessary.

Journal of Drugs in DermatologyVol. 24(11)
Openalex Percentile: Top 65%
Genetic and rare skin diseases.
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Management of Hailey-Hailey Disease With Ruxolitinib 1.5% Cream — Héctor Quijano Méndez, Jacob Beer, et al. · Journal of Drugs in Dermatology (2025) | TGRS Research Map | TGRS